These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8343276)
1. De novo cisplatinum resistance does not influence cellular radiosensitivity. Britten RA; Warenius HM Eur J Cancer; 1993; 29A(9):1315-20. PubMed ID: 8343276 [TBL] [Abstract][Full Text] [Related]
2. The differential induction of collateral resistance to 62.5 MeV (p-->Be+) neutrons and 4 MeV photons by exposure to cis-platinum. Britten RA; Warenius HM; Masters JR; Peacock JH Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):837-43. PubMed ID: 8344853 [TBL] [Abstract][Full Text] [Related]
3. Identification of human in vitro cell lines with greater intrinsic cellular radiosensitivity to 62.5 MeV (p-->Be+) neutrons than 4 MeV photons. Warenius HM; Britten RA; Browning PG; Morton IE; Peacock JH Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):913-20. PubMed ID: 8138445 [TBL] [Abstract][Full Text] [Related]
4. Collateral resistance to photon and neutron irradiation is associated with acquired cis-platinum resistance in human ovarian tumour cells. Britten RA; Peacock J; Warenius HM Radiother Oncol; 1992 Mar; 23(3):170-5. PubMed ID: 1574595 [TBL] [Abstract][Full Text] [Related]
5. The influence of hypoxia on the relative sensitivity of human tumor cells to 62.5 MeV (p-->Be) fast neutrons and 4 MeV photons. Warenius HM; White R; Peacock JH; Hanson J; Britten RA; Murray D Radiat Res; 2000 Jul; 154(1):54-63. PubMed ID: 10856966 [TBL] [Abstract][Full Text] [Related]
6. The inherent cellular sensitivity to 62.5 MeV(p----Be+) neutrons of human cells differing in photon sensitivity. Britten RA; Warenius HM; Parkins C; Peacock JH Int J Radiat Biol; 1992 Jun; 61(6):805-12. PubMed ID: 1351531 [TBL] [Abstract][Full Text] [Related]
7. In vitro studies of intrinsic cellular radiosensitivity following 4 MeV photons or 62.5 MeV (p-->Be+) neutrons. Potential implications for high LET therapy. Warenius HM; Britten RA Acta Oncol; 1994; 33(3):241-9. PubMed ID: 8018352 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the potential therapeutic gain of p(66)/Be neutrons and d(14)/Be neutrons. Slabbert JP; Theron T; Zolzer F; Streffer C; Bohm L Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1059-65. PubMed ID: 10863079 [TBL] [Abstract][Full Text] [Related]
9. The relative cellular radiosensitivity of 30 human in vitro cell lines of different histological type to high LET 62.5 MeV (p-->Be+) fast neutrons and 4 MeV photons. Warenius HM; Britten RA; Peacock JH Radiother Oncol; 1994 Jan; 30(1):83-9. PubMed ID: 8153385 [TBL] [Abstract][Full Text] [Related]
10. Influence of cisplatinum on intestinal tolerance to photon and neutron irradiation in mice. Lambin P; Scalliet P; Coster B; M'Vondo JC; Vynckier S; Gueulette J; Wambersie A Radiother Oncol; 1993 Jan; 26(1):73-5. PubMed ID: 8438090 [TBL] [Abstract][Full Text] [Related]
11. The merits of cell kinetic parameters for the assessment of intrinsic cellular radiosensitivity to photon and high linear energy transfer neutron irradiation. Theron T; Slabbert J; Serafin A; Böhm L Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):423-8. PubMed ID: 9069317 [TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity variations in human tumor cell lines exposed in vitro to p(66)/Be neutrons or 60Co gamma-rays. Slabbert JP; Theron T; Serafin A; Jones DT; Böhm L; Schmitt G Strahlenther Onkol; 1996 Oct; 172(10):567-72. PubMed ID: 8899008 [TBL] [Abstract][Full Text] [Related]
13. Radiation response of human lung cancer cells with inherent and acquired resistance to cisplatin. Twentyman PR; Wright KA; Rhodes T Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):217-20. PubMed ID: 1846846 [TBL] [Abstract][Full Text] [Related]
14. Induction of cisplatinum sensitivity without alteration in radiation sensitivity by fractionated radiation treatment of a human laryngeal squamous cell carcinoma cell line. Redpath JL; Hyden EC; Sun C Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):681-5. PubMed ID: 7790254 [TBL] [Abstract][Full Text] [Related]
15. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines. Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652 [TBL] [Abstract][Full Text] [Related]
16. Radiosensitivity, recovery and dose-rate effect in three human glioma cell lines. Yang X; Darling JL; McMillan TJ; Peacock JH; Steel GG Radiother Oncol; 1990 Sep; 19(1):49-56. PubMed ID: 2122495 [TBL] [Abstract][Full Text] [Related]
17. Differential sensitization of human tumor cells by ara-A to X irradiation and its relationship to inherent radioresponse. Dahlberg WK; Little JB Radiat Res; 1992 Jun; 130(3):303-8. PubMed ID: 1594756 [TBL] [Abstract][Full Text] [Related]
18. Micronucleus response of human glioblastoma and neuroblastoma cells toward low-LET photon and high-LET p(66)/Be neutron irradiation. Akudugu JM; Slabbert JP; Roos WP; Böhm L Am J Clin Oncol; 2003 Jun; 26(3):e1-6. PubMed ID: 12796609 [TBL] [Abstract][Full Text] [Related]
19. Inherent radiosensitivity and split-dose recovery in plateau-phase cultures of 10 human tumour cell lines. Courdi A; Bensadoun RJ; Gioanni J; Caldani C Radiother Oncol; 1992 Jun; 24(2):102-7. PubMed ID: 1496140 [TBL] [Abstract][Full Text] [Related]
20. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines. Aldridge DR; Radford IR Cancer Res; 1998 Jul; 58(13):2817-24. PubMed ID: 9661896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]